Back to CGEM

Affinity Asset Advisors, LLC → CGEM

Affinity Asset Advisors, LLC CGEM Position History

Cullinan Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$13.4M
Q3 2026
Peak value
$20M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$20M
Q1 2026$11.1M
Q2 2026$15.9M
Q3 2026$13.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$13.4M875.8K——
Q2 2026$15.9M875.8K——
Q1 2026$11.1M781.3K——
Q4 2025$20M1.93M——

Other funds holding CGEM

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M